272 related articles for article (PubMed ID: 8004720)
1. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
Lee K; Tashiro T; Noji M
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and antitumor activity of 1,2-bis(diphenylphosphino) ethane platinum(II) and palladium(II) complexes.
Khokhar AR; Xu QY; Siddik ZH
J Inorg Biochem; 1990 Jun; 39(2):117-23. PubMed ID: 2380705
[TBL] [Abstract][Full Text] [Related]
3. Platinum and palladium complexes of 3-methyl orotic acid: a route toward palladium complexes with good antitumor activity.
Castan P; Colacio-Rodriguez E; Beauchamp AL; Cros S; Wimmer S
J Inorg Biochem; 1990 Mar; 38(3):225-39. PubMed ID: 2329345
[TBL] [Abstract][Full Text] [Related]
4. Platinum and palladium derivatives for chemotherapy studies.
Bahner CT; Patterson TC; Rives LM; Harmon HD
J Med Chem; 1979 May; 22(5):575-7. PubMed ID: 458809
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activities of platinum complexes of unsymmetrical alicyclic diamines as carrier ligands.
Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
J Pharm Sci; 1990 Aug; 79(8):750-3. PubMed ID: 2231341
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of platinum complexes of 2-aminomethylpyrrolidine derivatives for use as carrier ligands and their antitumor activities.
Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):930-5. PubMed ID: 2379286
[TBL] [Abstract][Full Text] [Related]
8. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds].
Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M
Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509
[TBL] [Abstract][Full Text] [Related]
9. Unsymmetrical C-substituted ethylenediamine platinum coordination complexes: synthesis and activity against mouse leukemia L1210.
Hall LM; Speer RJ; Ridgway HJ; Norton SJ
J Inorg Biochem; 1979 Oct; 11(2):139-49. PubMed ID: 501351
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands.
Khokhar AR; Deng Y; Kido Y; Siddik ZH
J Inorg Biochem; 1993 May; 50(2):79-87. PubMed ID: 8487040
[TBL] [Abstract][Full Text] [Related]
11. Platinum(IV) chloride complexes with heterocyclic ligands.
Massacesi M; Pinna R; Ponticelli G; Puggioni G
J Inorg Biochem; 1987 Feb; 29(2):95-100. PubMed ID: 3559551
[TBL] [Abstract][Full Text] [Related]
12. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds].
Malinowska K; Modranka R; Kubiak K; Mrowicka M; Kedziora J; Klimczak A; Rutkowski M
Pol Merkur Lekarski; 2009 Jan; 26(151):52-6. PubMed ID: 19391508
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
14. Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
Mailliet P; Segal-Bendirdjian E; Kozelka J; Barreau M; Baudoin B; Bissery MC; Gontier S; Laoui A; Lavelle F; Le Pecq JB
Anticancer Drug Des; 1995 Jan; 10(1):51-73. PubMed ID: 7695813
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
[TBL] [Abstract][Full Text] [Related]
16. Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2- phenylethylenediamine](sulfato)platinum-(II) complexes with variable substituents in the 2-phenyl ring. 1. Synthesis and antitumor and estrogenic properties.
Gust R; Burgemeister T; Mannschreck A; Schönenberger H
J Med Chem; 1990 Sep; 33(9):2535-44. PubMed ID: 2391694
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, DNA binding and cytotoxic studies of platinum(II) and palladium(II) complexes of the 2,2'-bipyridine and an anion of 1,1-cyclobutanedicarboxylic acid.
Mansuri-Torshizi H; Ghadimy S; Akbarzadeh N
Chem Pharm Bull (Tokyo); 2001 Dec; 49(12):1517-20. PubMed ID: 11767068
[TBL] [Abstract][Full Text] [Related]
18. DNA-directed alkylating agents. 2. Synthesis and biological activity of platinum complexes linked to 9-anilinoacridine.
Palmer BD; Lee HH; Johnson P; Baguley BC; Wickham G; Wakelin LP; McFadyen WD; Denny WA
J Med Chem; 1990 Nov; 33(11):3008-14. PubMed ID: 2231598
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor platinum(II) complexes with substituted 2-aminomethylpyridine ligands].
Brunner H; Nerl G; von Angerer E; Knebel N
Arch Pharm (Weinheim); 1991 Oct; 324(10):779-84. PubMed ID: 1805710
[TBL] [Abstract][Full Text] [Related]
20. New platinum (II) and platinum (IV) complexes with 1,2-diaminocyclohexane. Synthesis and in vitro and in vivo antitumour evaluation.
Craciunescu DG; Furlani Candiani A; Scarcia V; Doadrio A; Ghirvu C
J Pharm Belg; 1985; 40(2):79-84. PubMed ID: 4009393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
